Investor Presentaiton
Select Key Financial and Operating Metrics
(in 000s) unless indicated
Net revenue
Q4-19
Q4-18
% CHANGE
16,290
3,190
411%
Cost of sales (incl. indirect production)
15,543
1,586
880%
Gross margin (GM) before FV changes
747
1,604
(53)%
FV changes to bio assets & inventories
(11,806)
30,846
n/m
Gross margin
SG&A¹
(11,059)
32,450
n/m
13,883
3,567
289%
Net income (loss) from continuing ops
(22,456)
18,091
n/m
Select Non-IFRS Financial Metrics
GM before FV changes as % of net revenue
5%
50%
(46)%
SG&A as a % of net revenue
Adjusted EBITDA²
85%
112%
(27)%
(7,907)
292
n/m
Adjusted EBITDA as a % of net revenue²
n/m
9%
n/m
Select Operating Metrics
Cost of cultivation per gram harvested³
0.94
0.83
13%
Kilograms harvested
7,434
6,322
18%
Kilograms sold-DFE equivalents4
2,898
399
626%
1 Sales and marketing and general and administrative expenses (excludes noncash share based compensation and impairment loss).
Adjusted EBITDA is a non-IFRS measure-please see final slide.
2
20
3
Cost of cultivation is a non-IFRS measure-please see final slide.
4
DFE or dried flower equivalents- flower and oil - is a non-IFRS measure and is based on the conversion of oil sales to an equivalent measure at a stardard rate of 9.0 mL/g
for recreational oil and 4.5 mL/g for medical oil
ORGANIGRAMView entire presentation